Cypress Capital Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-354
| Closed | -$372K | – | 296 |
|
|
2024
Q3 | $372K | Buy |
354
+3
| +0.9% | +$3.15K | 0.04% | 246 |
|
|
2024
Q2 | $369K | Sell |
351
-41
| -10% | -$43.1K | 0.04% | 234 |
|
|
2024
Q1 | $377K | Sell |
392
-1,010
| -72% | -$972K | 0.05% | 235 |
|
|
2023
Q4 | $1.23M | Sell |
1,402
-10
| -0.7% | -$8.78K | 0.16% | 115 |
|
|
2023
Q3 | $1.16M | Sell |
1,412
-298
| -17% | -$245K | 0.17% | 117 |
|
|
2023
Q2 | $1.23M | Buy |
1,710
+59
| +4% | +$42.4K | 0.18% | 121 |
|
|
2023
Q1 | $1.36M | Sell |
1,651
-13
| -0.8% | -$10.7K | 0.21% | 110 |
|
|
2022
Q4 | $1.2M | Buy |
1,664
+77
| +5% | +$55.6K | 0.18% | 120 |
|
|
2022
Q3 | $1.09M | Buy |
+1,587
| New | +$1.09M | 0.18% | 116 |
|
|
2021
Q1 | – | Sell |
-713
| Closed | -$344K | – | 290 |
|
|
2020
Q4 | $344K | Sell |
713
-43
| -6% | -$20.7K | 0.05% | 230 |
|
|
2020
Q3 | $423K | Buy |
756
+32
| +4% | +$17.9K | 0.07% | 197 |
|
|
2020
Q2 | $452K | Buy |
724
+189
| +35% | +$118K | 0.08% | 179 |
|
|
2020
Q1 | $261K | Sell |
535
-123
| -19% | -$60K | 0.06% | 177 |
|
|
2019
Q4 | $247K | Buy |
+658
| New | +$247K | 0.04% | 220 |
|
|
2016
Q1 | – | Sell |
-868
| Closed | -$471K | – | 178 |
|
|
2015
Q4 | $471K | Hold |
868
| – | – | 0.11% | 127 |
|
|
2015
Q3 | $404K | Buy |
868
+161
| +23% | +$74.9K | 0.1% | 146 |
|
|
2015
Q2 | $361K | Hold |
707
| – | – | 0.08% | 160 |
|
|
2015
Q1 | $319K | Sell |
707
-140
| -17% | -$63.2K | 0.07% | 176 |
|
|
2014
Q4 | $347K | Buy |
847
+140
| +20% | +$57.4K | 0.08% | 167 |
|
|
2014
Q3 | $255K | Buy |
+707
| New | +$255K | 0.06% | 187 |
|
|
2014
Q2 | – | Sell |
-707
| Closed | -$212K | – | 213 |
|
|
2014
Q1 | $212K | Buy |
+707
| New | +$212K | 0.05% | 201 |
|
|
2013
Q4 | – | Sell |
-707
| Closed | -$221K | – | 215 |
|
|
2013
Q3 | $221K | Buy |
+707
| New | +$221K | 0.05% | 193 |
|